Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Inhaled Corticosteroids (ICS) Effects on Airway Gene Expression in Healthy Volunteers
NCT02476825Phase 4Active, not recruiting
- Sponsor
- University Hospitals of Leicester NHS Trust
- Start
- Jan 2016
- Primary completion
- Oct 2026
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
Phase 4, randomised, single-blind trial of fluticasone propionate in asthma (2 arms), sponsored by University Hospitals of Leicester NHS Trust. Primary endpoint: Relative change from baseline in airway tissue gene expression at 4 weeks. Started Jan 2016; status: active, not recruiting.
02
Drugs
fluticasone propionate
03
Conditions
asthma
Beyond the preview
Go deeper on NCT02476825.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02476825.